NVNO Projected Dividend Yield

enVVeno Medical Corp ( NASDAQ : NVNO )

enVVeno Medical is a late stage clinical med-tech company focused on the development of bioprosthetic (tissue-based) solutions. Co. is developing surgical and non-surgical replacement venous valves for patients suffering from severe Chronic Venous Insufficiency (CVI) of the deep venous system of the leg. Co.'s primary product is the VenoValve®, which is a porcine based replacement venous valve to be surgically implanted in the deep venous system of the leg to treat severe CVI. Co. is also developing a second product called enVVe™, which is a non-surgical, transcatheter based replacement venous valve for the treatment of CVI of the deep veins of the leg.

20 YEAR PERFORMANCE RESULTS